July 7, 2023
FDA briefing on 503B guidance draft
We reported last week that FDA had issued guidance on 503B wholesaling. Now, the agency has announced it will be presenting an overview of the guidance, with an opportunity to ask questions, on July 14, 2023, at 11:00am ET. You can tune into the live presentation via this Zoom link (no registration is required).
Please feel free to share this link with your colleagues.
